Vistra

Vistra Shares Fall Amid PJM's Revised Demand Forecast, Raising Concerns Over Financial Health and Regulatory Risks.

Vistra Corp Outperforms Utility Industry, Should You Invest in VST Stock?

UBS Raises VST Price Target to $233, Maintains Buy Rating

BMO Capital Raises Vistra Price Target to $244, Maintains "Outperform" Rating

Vistra Launches $2.25 Billion Bond Offering to Fund Strategic Initiatives and Manage Debt

Catalyst<ul> <li>Recent MACD Death Cross and MACD Golden Cross signals suggest bullish momentum for VST.</li> <li>Most analysts rate VST Buy or Strong Buy, showing broad institutional optimism.</li> <li>VST maintains strong asset and net asset per share growth factors relative to market value.</li></ul>Risk<ul> <li>Fund flows show overall negative trends across all order sizes, indicating investor caution.</li> <li>Technical indicators remain mixed with unclear directional signals, increasing uncertainty for traders.</li></ul>

Key Factors

Vistra (VST) secured a 20-year power purchase agreement with Meta to supply 2,600 megawatts of zero-carbon nuclear energy from PJM-region plants.Vistra launched a $2.25 billion senior secured notes offering to fund its Cogentrix Energy acquisition and general corporate purposes.Vistra’s stock surged 15.57% premarket following the Meta nuclear agreement and its $4.7 billion Cogentrix Energy acquisition announcement.UBS raised its price target for Vistra to $233 per share, maintaining a Buy rating based on improved growth visibility.BMO Capital increased its price target for Vistra to $244 from $230, maintaining an Outperform rating.

VST News